Rupeedesk Consultancy

Indian Market Weekly Outlook & Sectorwise Stocks Outlook for the Week - 11.Jul.2016 to 15.Jul.2016

Click The Below Links To Read Full Reports

Indian Markets Outlook for the week – 11.Jul.2016 to 15.Jul.2016 (Economic data, Apr-Jun results key triggers next week)


Given the satisfactory progress of the monsoon in the country so far, stock indices are seen trading
with a positive bias next week, with corporate earnings for Apr-Jun and key economic data driving the trend in domestic stocks. Among Nifty 50 constituents, IndusInd Bank, Infosys, Reliance Industries and Tata Consultancy Services are scheduled to detail their Apr-Jun earnings during the coming week.

Data on Consumer Price Index-based inflation for June, as well as that on the Index of Industrial
Production for May will be released on Tuesday. On Thursday, data on Wholesale Price Index-based
inflation is to be released. India's headline inflation, based on the CPI, had risen to a 21-month high of 5.76% in May from 5.47% a month ago, while annual inflation based on the WPI rose to 0.79% in May from 0.34% a month ago.

Next week, the Nifty 50 is seen trading in the range of 8200-8500 points, with immediate support at
8280 points. Today, the index ended at 8323.20, down 14.70 points or 0.2% from the previous close.
The S&P BSE Sensex ended at 27126.90, down 74.59 points or 0.3% from Thursday.

Among stocks, stocks of pharmaceutical companies are seen extending gains, as recent approvals and
news of inspection clearances for select companies has lifted sentiment for the sector. Yesterday Alembic Pharmaceuticals and Cadila Healthcare ended 3.3% and 5% higher, respectively, after both companies received establishment inspection reports from the US Food and Drug Administration for one unit each. Lupin, however, said the US FDA had issued Form 483 to its Dabhasa plant in Gujarat and made two observations, following an inspection carried out during Jun 29-Jul 6. )